Imunon, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Imunon, Inc. (IMNN) had Deferred Tax Assets, Operating Loss Carryforwards of $75.15 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $75.15M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $66.14M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $67.31M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $79.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $75.15M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $66.14M 10-K · filed 2026-03-31 | |
| 2023-12-31 | $67.31M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $79.80M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $64.92M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $60.45M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $58.24M 10-K · filed 2021-03-19 | |
| 2018-12-31 | $51.50M 10-K · filed 2020-03-25 | |
| 2017-12-31 | $62.22M 10-K · filed 2019-03-29 | |
| 2016-12-31 | $81.33M 10-K · filed 2018-03-27 | $80.92K 10-K · filed 2017-03-24 |
| 2015-12-31 | $71.56K 10-K · filed 2017-03-24 | $71.56M 10-K · filed 2016-03-30 |
| 2014-12-31 | $64.02M 10-K · filed 2016-03-30 | $61.54M 10-K · filed 2015-03-12 |
| 2013-12-31 | $53.42M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $49.27M 10-K · filed 2014-03-13 | $49.41M 10-K · filed 2013-03-18 |
| 2011-12-31 | $40.10M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |